Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FloR COVID-19
NCT04570449Phase 1Withdrawn
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Fluoxetine with Placebo (2 arms). Primary endpoints: Rate of hospitalization at 8 weeks and Physical symptoms assessed through daily checklist at 8 weeks. Planned start Nov 2020; status: withdrawn.
02
Drugs
fluoxetine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04570449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04570449.